• Palbace 125mg - Palbociclip

Palbace 125mg - Palbociclip

  • Palbociclip
  • Ibrance
  • 125mg
  • Pfizer

Avalon Pharma Pvt Ltd are suppliers and exporters of Palbace (Palbociclip 125mg) from India.

Palbociclib is an oral chemotherapy used to treat advanced breast cancer. This drug is used as part of a combination therapy. That means it is taken with other drugs. Palbociclib is generally taken in combination with letrozole

Palbace (Palbociclip 125mg) ) is a product of Pfizerand is known as IBRANCE in other parts of the world

The drug was reviewed and approved under the Food and Drug Administration’s (FDA) accelerated Priority Review and Breakthrough Therapy designation programs on February of 2015

The drug was approved for use in the European Union in November 2016 as a treatment for hormone receptor (HR) positive, human epidermal growth factor receptor 2 (HER2) negative locally advanced or metastatic breast cancer

Palbace comes in capsule form in 125 mg dose. 1 pack has 21 capsules.